JAMIE INTERLICHIA: Open Payments
NPI 1124278841 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 7 payments from 7 companies in 2025. Trend: 2023 $1,056 · 2024 $1,037 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $147 |
| Pharmacosmos Therapeutics Inc. | 1 | $145 |
| TG Therapeutics, Inc. | 1 | $137 |
| Grifols USA, LLC | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| SANOFI-AVENTIS U.S. LLC | 1 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $63 |
Products named: REZDIFFRA, MONOFERRIC, BRIUMVI, Prolastin-C Liquid, UZEDY, TZIELD, Kerendia.
Industry payments across NY — which companies pay providers there.
